ORGANIZATION
Industry Leaders Issue Statements on FY2020 Reform Package; Improved PMP Criteria Given Certain Credit
Pharma industry chieftains on December 20 issued their statements for a package of reform plans approved on the day for the FY2020 drug pricing reform next April, with proposed revisions to the price maintenance premium (PMP) credited as “a certain…
To read the full story
Related Article
- Japan Panel Hammers Out FY2020 Drug Pricing Reform
December 20, 2019
ORGANIZATION
- PhRMA Sues CMS over Medicare MFN Model, Calls It Unlawful Overreach
October 9, 2026
- Japan Generic Group Calls for Clearer Patent Extension Rules
October 9, 2026
- 3 Pharma Groups Press Government to Rethink CEA Expansion
October 8, 2026
- JPMA Chief Urges Manufacturing, Talent Push to Build Drug Discovery Ecosystem
October 8, 2026
- PhRMA Taps Jonathan Kushner as New Japan Representative
October 6, 2026
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…





